Atlas Trials

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

Clinical trial NCT01073462 · COMPLETED

Trial details

NCT number
NCT01073462
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Study type
OBSERVATIONAL
Secondary HyperparathyroidismChronic Kidney Disease Stage VCardiac Morbidity
Start date
2008-12-01
Primary completion
2013-06-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.